Literature DB >> 33436332

Multivalent Probes in Molecular Imaging: Reality or Future?

Verena I Böhmer1, Wiktor Szymanski2, Ben L Feringa3, Philip H Elsinga4.   

Abstract

The rapidly developing field of molecular medical imaging focuses on specific visualization of (patho)physiological processes through the application of imaging agents (IAs) in multiple clinical modalities. Although our understanding of the principles underlying efficient IAs design has increased tremendously, many IAs still show poor in vivo imaging performance because of low binding affinity and/or specificity. These limitations can be addressed by taking advantage of multivalency, in which multiple copies of a ligand are employed to strengthen the interaction. We critically address specific challenges associated with the application of multivalent compounds in molecular imaging, and we give directions for a stepwise approach to the design of multivalent imaging probes to improve their target binding and pharmacokinetics (PK) for improved diagnostic potential.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  avidity; binding affinity; imaging probes; multivalency, molecular imaging

Mesh:

Substances:

Year:  2021        PMID: 33436332     DOI: 10.1016/j.molmed.2020.12.006

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  3 in total

Review 1.  Optical molecular imaging and theranostics in neurological diseases based on aggregation-induced emission luminogens.

Authors:  Peili Cen; Youyou Zhou; Chunyi Cui; Yen Wei; Zhen Cheng; Shuizhu Wu; Hong Zhang; Mei Tian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-04       Impact factor: 9.236

2.  ES-MION-Based Dual-Modality PET/MRI Probes for Acidic Tumor Microenvironment Imaging.

Authors:  Xiuyan Wei; Haitao Zhao; Gang Huang; Jianhua Liu; Weina He; Qingqing Huang
Journal:  ACS Omega       Date:  2022-01-18

3.  PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin.

Authors:  Neil Gerard Quigley; Katja Steiger; Sebastian Hoberück; Norbert Czech; Maximilian Alexander Zierke; Susanne Kossatz; Marc Pretze; Frauke Richter; Wilko Weichert; Christian Pox; Jörg Kotzerke; Johannes Notni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-09-24       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.